Patents by Inventor David Piper

David Piper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11951929
    Abstract: An occupant protection system for a vehicle may include an expandable curtain and/or an expandable bladder configured to be expanded from a stowed state to a deployed state. In the deployed state, the expandable curtain may include first and second sides configured to extend along respective portions of first and second interior sides of the vehicle. The expandable curtain may also include a transverse portion extending between the first and second sides, and the first and second sides, and the transverse portion of the expandable curtain may form a contiguous barrier. The expandable bladder when deployed may be supported by the expandable curtain during contact by an occupant. The occupant protection system may also include a deployment control system configured to cause the expandable curtain and/or the expandable bladder to expand to the deployed state. The occupant protection system may be used in vehicles having a carriage-style seating arrangement.
    Type: Grant
    Filed: June 9, 2022
    Date of Patent: April 9, 2024
    Assignee: Zoox, Inc.
    Inventors: Markus Jost, Timothy David Kentley-Klay, Andrew John Piper, Josh Alexander Jimenez
  • Publication number: 20240100772
    Abstract: A three-dimensional printer for the additive manufacturing of a part is provided. The printer includes a build platen, a pre-extrusion system, and a print head located downstream of the pre-extrusion system and configured to receive and deposit a filament. The print head includes a receiving section configured to receive the filament, an outlet through which the filament is deposited onto the build platen or a previously added layer of a part, a feeding mechanism constructed and arranged to feed the filament into the outlet, and a path length adjustment system positioned on the print head disposed between the pre-extrusion system and the feeding mechanism. The path length adjustment system constructed and arranged to create slack in the filament being delivered from the pre-extrusion system. Path length adjustment devices incorporating sliding components and flexure components are also disclosed.
    Type: Application
    Filed: September 21, 2023
    Publication date: March 28, 2024
    Inventors: Benjamin Fine, Nathaniel Berman, Angus MacMullen, David Piper, Nicholas Kalweit, Peter Kelly
  • Publication number: 20240085975
    Abstract: Apparatus, systems, and methods are provided for generating a quantified indicator of cognitive skills in an individual. In certain configurations, the apparatus, systems, and methods can be implemented for enhancing cognitive skills in an individual.
    Type: Application
    Filed: November 22, 2023
    Publication date: March 14, 2024
    Inventors: Titiimaea Alailima, Jeffrey Bower, Jason Johnson, Ashley Mateus, Elena CaƱadas Espinosa, Adam Piper, Matthew Omernick, David Collins
  • Publication number: 20230231789
    Abstract: Systems and methods for network quality testing are provided. Synthetic traffic may be sent through a first flow path and a second flow path. The second flow path includes a portion apportionable to the first flow path, internal to a server, and a portion apportionable to an external flow path, external to the server. Durations of traffic traveling through the first flow path and the second flow path are compared to determine the portion of the second flow path apportionable to the external flow path. In an example, time stamping may be performed by component(s) of the server, such as a kernel, to determine the durations of the traffic traveling through the first flow path and the second flow path.
    Type: Application
    Filed: October 27, 2022
    Publication date: July 20, 2023
    Applicant: Level 3 Communications, LLC
    Inventors: Kenneth BROOKMAN, David PIPER
  • Publication number: 20210228801
    Abstract: Devices and methods for administering a medication in fluid form, the systems and methods including a basal flow path and a bolus flow path in parallel to the basal flow path. The bolus flow path includes a combined piston pump and rotatable valve. The piston pump is configured to prevent partial dosing of a bolus dose.
    Type: Application
    Filed: April 15, 2021
    Publication date: July 29, 2021
    Inventors: Hermanus Stephanus Pretorius, Robert Farra, Kenneth Barnett, David Piper, Russell Ford, Edward G. Solomon, Peter Holst, Lawrence Smith
  • Patent number: 11007317
    Abstract: Devices and methods for administering a medication in fluid form, the systems and methods including a basal flow path and a bolus flow path in parallel to the basal flow path. The bolus flow path includes an inlet check valve, a first outlet check valve downstream of the inlet check valve, and a piston pump disposed between the inlet check valve and the first outlet check valve. The piston pump is configured to prevent partial dosing of a bolus dose.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: May 18, 2021
    Assignee: CEQUR SA
    Inventors: Hermanus Stephanus Pretorius, Robert Farra, Kenneth Barnett, David Piper, Russell Ford, Edward G. Solomon, Peter Holst, Lawrence Smith
  • Publication number: 20190336680
    Abstract: Devices and methods for administering a medication in fluid form, the systems and methods including a basal flow path and a bolus flow path in parallel to the basal flow path. The bolus flow path includes an inlet check valve, a first outlet check valve downstream of the inlet check valve, and a piston pump disposed between the inlet check valve and the first outlet check valve. The piston pump is configured to prevent partial dosing of a bolus dose.
    Type: Application
    Filed: May 2, 2019
    Publication date: November 7, 2019
    Inventors: Hermanus Stephanus Pretorius, Robert Farra, Kenneth Barnett, David Piper, Russell Ford, Edward G. Solomon, Peter Holst, Lawrence Smith
  • Patent number: 8876457
    Abstract: A railroad tie stacker arrangement includes means for conveying ties to a tie accumulation deck to form a layer of parallel ties, means for conveying the layer of parallel ties onto a stack accumulation lift, and means for lowering the stack accumulation lift as each successive layer of ties is deposited onto the lift.
    Type: Grant
    Filed: September 25, 2012
    Date of Patent: November 4, 2014
    Assignee: Brewco, Inc.
    Inventor: David Piper
  • Patent number: 8596263
    Abstract: The present invention is directed generally to a nebulizer for the formation of micro-droplets from liquid medicaments for respiratory patient treatment, and more specifically, to a baffled nebulizer wherein a static baffle used to form an atomized medicament is proximal to a shied which responds to patient respiration force to oscillate from an aerosol flow occluding position to an aerosol flow open position. During inhalation, the shield moves into a first registration format to allow passage of the atomized medicament (nebula) to the patient. During exhalation/non-use, a biasing pressure maintains said shield in a second registration format such that the nebula is retarded from passing to the patient and is coalesced into macro-droplets which return to a supply reservoir for re-atomization.
    Type: Grant
    Filed: November 12, 2010
    Date of Patent: December 3, 2013
    Inventor: Samuel David Piper
  • Publication number: 20120231541
    Abstract: Disclosed are assays, methods, and kits for the screening of test compounds for their capability to induce cardiotoxicity in a subject. In particular, whether a test compound has the effect to prolong the Q-T interval as measured by an electrocardiogram in a human. The assays, methods, and kits disclosed herein make use of the binding interaction between novel fluorescent tracers and the hERG K+ channel, and the propensity of a test compound to influence that binding interaction.
    Type: Application
    Filed: March 9, 2012
    Publication date: September 13, 2012
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: David Piper, Stephen Hess, Mohammed Saleh Shekhani, Thomas Livelli, Zhong Zhong, Steve Duff, Kurt Vogel
  • Patent number: 8133695
    Abstract: Disclosed are assays, methods, and kits for the screening of test compounds for their capability to induce cardiotoxicity in a subject. In particular, whether a test compound has the effect to prolong the Q-T interval as measured by an electrocardiogram in a human. The assays, methods, and kits disclosed herein make use of the binding interaction between novel fluorescent tracers and the hERG K+ channel, and the propensity of a test compound to influence that binding interaction.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: March 13, 2012
    Assignee: Life Technologies Corporation
    Inventors: David Piper, Kurt Vogel, Mohammed Saleh Shekhani, Stephen Hess, Steve Duff, Thomas Livelli, Zhong Zhong
  • Publication number: 20110200683
    Abstract: The present invention is directed generally to a first aid treatment package the contents of which can be mixed with available water to create a solution useful for the treatment of wounds, and more specifically, a first aid treatment package the contents of which include a adduct of hydrogen peroxide which when mixed with available water create a hydrogen peroxide solution for the first aid treatment of wounds in remote locations or under circumstances when normal community resources are unavailable.
    Type: Application
    Filed: February 15, 2011
    Publication date: August 18, 2011
    Applicant: Piper Medical, Inc
    Inventor: Samuel David Piper
  • Publication number: 20110120473
    Abstract: The present invention relates generally to devices and methods for finite control and regulation of patient intrathoracic pressures, and more specifically, to devices and methods that finitely regulates a patient's intrathoracic pressures during repeated cycling events (i.e. respiration) by use of a cross-seal vent valve to form transient pressure windows. The cross-seal vent valve is biased against the pressure necessary to evacuate and/or inflate the lungs of that patient, while a controlled venting of that pressure by at least a partial volume thereof allows for controlled resetting of the baseline pressure to anatomical norms. This enhanced means for regulating intrathoracic pressure are applicable in a number of medically important therapies, including but not limited to, conditioning of pulmonary systems for acclimation to altered environmental conditions, reconditioning of pulmonary system after operating in a diminished state, and application in cardiopulmonary resuscitation procedures.
    Type: Application
    Filed: November 22, 2010
    Publication date: May 26, 2011
    Applicant: Piper Medical, Inc.
    Inventor: Samuel David Piper
  • Publication number: 20110124115
    Abstract: The present invention pertains generally to colorimetric indicia provided by a primary device, and more particularly, to at least one indicator moiety influenced by changing environments wherein the indicator moiety exhibits a rapid initial response and a protracted transient time for visualization by an operator. As compared to heretofore colorimetric indicator technologies, the present invention allows for improved accuracy of data interpretation by direct visual capture of changing environments with shorter duration transients.
    Type: Application
    Filed: November 22, 2010
    Publication date: May 26, 2011
    Applicant: Piper Medical Inc
    Inventor: Samuel David Piper
  • Publication number: 20110114090
    Abstract: The present invention is directed generally to a nebulizer for the formation of micro-droplets from liquid medicaments for respiratory patient treatment, and more specifically, to a baffled nebulizer wherein a static baffle used to form an atomized medicament is proximal to a shied which responds to patient respiration force to oscillate from an aerosol flow occluding position to an aerosol flow open position. During inhalation, the shield moves into a first registration format to allow passage of the atomized medicament (nebula) to the patient. During exhalation/non-use, a biasing pressure maintains said shield in a second registration format such that the nebula is retarded from passing to the patient and is coalesced into macro-droplets which return to a supply reservoir for re-atomization.
    Type: Application
    Filed: November 12, 2010
    Publication date: May 19, 2011
    Applicant: Piper Medical, Inc.
    Inventor: Samuel David Piper
  • Publication number: 20100310425
    Abstract: The present invention pertains generally to a detection means for indicia provided by a primary device, and more particularly, to a detection sensor assembly adapted to measure at least one indicator moiety influenced by changing gaseous environments. A detection sensor assembly performs to collect and respond to changing gaseous environments in real-time, conveying that information to a user of the detection sensor assembly sufficiently quickly and accurately such that the user can respond to the changing gaseous environments in a timely manner. The detection sensor assembly operates using an incident receiver in the form of an indicator sensor. An indicator moiety responsive to particular elements or compounds of interest in a gaseous environment is positioned proximal to the indicator sensor such that changes in the indicator moiety are captured by operation of the indicator sensor.
    Type: Application
    Filed: June 4, 2010
    Publication date: December 9, 2010
    Applicant: Piper Medical, Inc.
    Inventor: Samuel David Piper
  • Publication number: 20100095965
    Abstract: The present invention relates generally to devices and methods for finite control and regulation of patient intrathoracic pressures, and more specifically, to devices and methods that are finitely adjustable within a range set by an operator for regulating a patient intrathoracic pressures during repeated cycling events (i.e. respiration). The enhanced means includes a dual area valve on an exhalation and/or inhalation port of a device such that the valve is biased against the pressure necessary to evacuate and/or inflate the lungs of that patient by at least a partial volume thereof. The enhanced means for regulating intrathoracic pressure are applicable in a number of medically important therapies, including but not limited to, conditioning of pulmonary systems for acclimation to altered environmental conditions, reconditioning of pulmonary system after operating in a diminished state, and application in cardiopulmonary resuscitation procedures.
    Type: Application
    Filed: October 16, 2009
    Publication date: April 22, 2010
    Inventor: S. David Piper
  • Publication number: 20090272377
    Abstract: The present invention is directed generally to a nebulizer for the formation of micro-droplets from liquid medicaments for respiratory patient treatment, and more specifically, to a baffled nebulizer wherein the baffle oscillates within the nebulizer. The oscillating baffle operates such that as a constant stream of liquid medicament strikes a target region within the oscillating baffle, at a first position the medicament stream forms a predominant fraction of macro-droplets, which are substantially recycled, and in a second position, the medicament stream forms a predominant fraction of micro-droplet respirable aerosol. The oscillating baffle moves between the first and second positions based upon the respiration of the patient, thus moving the oscillating baffle into the second position only when inhalation occurs, thereby preventing excessive waste of liquid medicament, and improving patient therapy.
    Type: Application
    Filed: April 21, 2009
    Publication date: November 5, 2009
    Inventor: Samuel David Piper, II
  • Publication number: 20090253148
    Abstract: Disclosed are assays, methods, and kits for the screening of test compounds for their capability to induce cardiotoxicity in a subject. In particular, whether a test compound has the effect to prolong the Q-T interval as measured by an electrocardiogram in a human. The assays, methods, and kits disclosed herein make use of the binding interaction between novel fluorescent tracers and the hERG K+ channel, and the propensity of a test compound to influence that binding interaction.
    Type: Application
    Filed: February 27, 2009
    Publication date: October 8, 2009
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: David Piper, Stephen Hess, Mohammed Saleh Shekhani, Thomas Livelli, Zhong Zhong, Steve Duff, Kurt Vogel
  • Publication number: 20080257348
    Abstract: This invention pertains generally to ventilation devices, and more particularly to a low cost constant pressure, variable flow blower powered ventilation device that is fully functional with a mask and which can be adapted to a number of applications including (1) a respiratory device used for automatic resuscitation of patients needing emergency ventilation, (2) emergency backup ventilation capabilities for hospitals and other healthcare institutions, and (3) positive pressure support therapy for patients suffering from obstructive sleep apnea among other diseases and respiratory conditions.
    Type: Application
    Filed: April 21, 2008
    Publication date: October 23, 2008
    Inventor: S. David Piper